Citadel Advisors’s Equillium EQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,000
Closed -$43.4K 13286
2025
Q4
$43.4K Buy
28,000
+10,000
+56% +$12.2K ﹤0.01% 12098
2025
Q3
$25.7K Buy
+18,000
New +$19K ﹤0.01% 12437
2025
Q2
Sell
-13,200
Closed -$5.18K 13193
2025
Q1
$5.18K Buy
+13,200
New +$9.83K ﹤0.01% 13834
2024
Q2
Sell
-10,000
Closed -$23.1K 14534
2024
Q1
$23.1K Buy
10,000
+4,100
+69% +$7.13K ﹤0.01% 12908
2023
Q4
$4.27K Sell
5,900
-3,000
-34% -$1.78K ﹤0.01% 13523
2023
Q3
$6.59K Sell
8,900
-12,400
-58% -$9.94K ﹤0.01% 13311
2023
Q2
$16K Hold
21,300
﹤0.01% 12917
2023
Q1
$15.5K Sell
21,300
-15,800
-43% -$15.1K ﹤0.01% 13249
2022
Q4
$40.8K Sell
37,100
-20,000
-35% -$32.1K ﹤0.01% 12388
2022
Q3
$127K Buy
57,100
+41,400
+264% +$98.8K ﹤0.01% 10877
2022
Q2
$32K Buy
+15,700
New +$39.4K ﹤0.01% 12183
2022
Q1
Sell
-12,500
Closed -$47K 13828
2021
Q4
$47K Buy
+12,500
New +$67.6K ﹤0.01% 13282

Other funds holding EQ

Citadel Advisors's EQ Position: Q1 2026 in Review

Citadel Advisors opened a new position in Equillium (EQ) in Q1 2026: 158,733 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #10352 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in EQ as recently as Q3 2025.

Citadel Advisors first reported a position in EQ in Q4 2018 and has held it in 15 quarters since. The position peaked at $867K in Q4 2018. 50 funds tracked by Wall St. Rank hold EQ as of Q1 2026.

  • Citadel Advisors held 158,733 shares of Equillium worth $317K as of Q1 2026.
  • Equillium was a new Citadel Advisors position in Q1 2026.
  • Equillium made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10352 holding.
  • Citadel Advisors first reported a position in Equillium in Q4 2018 and has held it in 15 quarters since.
  • Citadel Advisors's Equillium position peaked at $867K in Q4 2018.
  • 50 funds tracked by Wall St. Rank held Equillium as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.